| Financial Year |
March 31 2023 |
| Monetary Funds |
1,232,456,385.15 |
| Held-for-trading Financial Assets |
694,508.83 |
| Notes Receivable |
2,000,000.00 |
| Accounts Receivable |
777,306,892.97 |
| Advances to Suppliers |
47,061,705.03 |
| Other Receivables |
4,354,608.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
898,272,725.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
96,438,543.81 |
| Total Current Assets |
3,058,585,370.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
62,244,754.03 |
| Investment Properties |
-- |
| Fixed Assetes |
351,970,883.94 |
| Under-construction Projects |
32,209,129.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,607,257.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,677,446.97 |
| Deferred Income Tax Assets |
34,315,301.09 |
| Other Non-Current Assets |
7,354,610.68 |
| Sub-Total of Non-Current Assets |
575,555,114.50 |
| Total Assets |
3,634,140,485.02 |
| Short-Term Loans |
506,270,328.54 |
| Trading Financial liabilities |
110,383.73 |
| Notes Payable |
328,385,742.19 |
| Accounts Payable |
378,343,680.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,911,485.27 |
| Taxes Payable |
14,453,860.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,609,352.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
74,901,212.14 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,323,100,013.34 |
| Long-term Loans |
41,347,115.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,641,879.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
126,050,218.05 |
| Total Liabilities |
1,449,150,231.39 |
| Paid-In Capital(Or Share Stock) |
243,801,046.00 |
| Capital Surplus |
1,319,175,594.84 |
| Surplus Reserve |
18,881,017.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
592,881,645.67 |
| Minority Stockholder's Interest |
6,502,472.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,178,487,780.90 |
| Owner's Equity（Stockholder's Equity） |
2,184,990,253.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,634,140,485.02 |
